REPIDOSE FARMINTIC 5-1250 DISPOSITIF INTRARUMINAL A LIBERATION SEQUENTIELLE
REPIDOSE FARMINTIC 5-1250 DISPOSITIF INTRARUMINAL A LIBERATION SEQUENTIELLE
Authorised
- Oxfendazole
Product identification
Medicine name:
REPIDOSE FARMINTIC 5-1250 DISPOSITIF INTRARUMINAL A LIBERATION SEQUENTIELLE
Active substance:
- Oxfendazole
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxfendazole6250.00/milligram(s)1.00System
Pharmaceutical form:
-
Pulsatile-release intraruminal device
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal180dayViande et abats : 6 mois.
-
Milkno withdrawal periodEn l'absence de détermination d'un temps d'attente pour le lait, ne pas utiliser chez les animaux producteurs de lait destiné à la consommation humaine, en lactation ou en période de tarissement ni chez les génisses gestantes futures productrices de lait de consommation humaine.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- MSD Animal Health UK Ltd
- Intervet GesmbH
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4174466 6/1993
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/04/2025
